SHOP APOTH. UNSP.ADR/010 (SAE1) - Net Assets
Based on the latest financial reports, SHOP APOTH. UNSP.ADR/010 (SAE1) has net assets worth €479.20 Million EUR (≈ $560.24 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.21 Billion ≈ $1.42 Billion USD) and total liabilities (€735.10 Million ≈ $859.41 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check SHOP APOTH. UNSP.ADR/010 (SAE1) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €479.20 Million |
| % of Total Assets | 39.46% |
| Annual Growth Rate | 3.64% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 28.37 |
SHOP APOTH. UNSP.ADR/010 - Net Assets Trend (2021–2025)
This chart illustrates how SHOP APOTH. UNSP.ADR/010's net assets have evolved over time, based on quarterly financial data. Also explore SAE1 total asset value for the complete picture of this company's asset base.
Annual Net Assets for SHOP APOTH. UNSP.ADR/010 (2021–2025)
The table below shows the annual net assets of SHOP APOTH. UNSP.ADR/010 from 2021 to 2025. For live valuation and market cap data, see how much is SHOP APOTH. UNSP.ADR/010 worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €479.20 Million ≈ $560.24 Million |
-6.03% |
| 2024-12-31 | €509.97 Million ≈ $596.21 Million |
-7.62% |
| 2023-12-31 | €552.03 Million ≈ $645.38 Million |
+55.66% |
| 2022-12-31 | €354.63 Million ≈ $414.60 Million |
-14.63% |
| 2021-12-31 | €415.41 Million ≈ $485.66 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to SHOP APOTH. UNSP.ADR/010's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 15041800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €817.40 Million | 178.01% |
| Total Equity | €459.20 Million | 100.00% |
SHOP APOTH. UNSP.ADR/010 Competitors by Market Cap
The table below lists competitors of SHOP APOTH. UNSP.ADR/010 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Fiskars Oyj Abp
HE:FSKRS
|
$1.07 Billion |
|
Collegium Pharmaceutical Inc
NASDAQ:COLL
|
$1.07 Billion |
|
Shilpa Medicare Limited
NSE:SHILPAMED
|
$1.07 Billion |
|
Zhejiang Zomax Transmission
SHG:603767
|
$1.07 Billion |
|
RITES Limited
NSE:RITES
|
$1.07 Billion |
|
YCC CORP
KQ:232140
|
$1.07 Billion |
|
MAGYAR TELE.A ADR/5 UF100
F:MGYA
|
$1.07 Billion |
|
Henan Hengxing Science & Technology Co Ltd
SHE:002132
|
$1.07 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SHOP APOTH. UNSP.ADR/010's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 483,981,000 to 459,200,000, a change of -24,781,000 (-5.1%).
- Net loss of 37,700,000 reduced equity.
- New share issuances of 400,000 increased equity.
- Other factors increased equity by 12,519,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-37.70 Million | -8.21% |
| Share Issuances | €400.00K | +0.09% |
| Other Changes | €12.52 Million | +2.73% |
| Total Change | €- | -5.12% |
Book Value vs Market Value Analysis
This analysis compares SHOP APOTH. UNSP.ADR/010's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.20x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €22.96 | €4.54 | x |
| 2022-12-31 | €19.49 | €4.54 | x |
| 2023-12-31 | €26.26 | €4.54 | x |
| 2024-12-31 | €24.07 | €4.54 | x |
| 2025-12-31 | €22.83 | €4.54 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SHOP APOTH. UNSP.ADR/010 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -8.21%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1.28%
- • Asset Turnover: 2.42x
- • Equity Multiplier: 2.64x
- Recent ROE (-8.21%) is above the historical average (-11.93%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -17.86% | -7.00% | 1.35x | 1.89x | €-115.73 Million |
| 2022 | -21.89% | -6.45% | 1.65x | 2.06x | €-113.11 Million |
| 2023 | -2.31% | -0.67% | 1.76x | 1.96x | €-64.26 Million |
| 2024 | -9.40% | -1.92% | 2.36x | 2.07x | €-93.90 Million |
| 2025 | -8.21% | -1.28% | 2.42x | 2.64x | €-83.62 Million |
Industry Comparison
This section compares SHOP APOTH. UNSP.ADR/010's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $12,079,618,600
- Average return on equity (ROE) among peers: 4.41%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SHOP APOTH. UNSP.ADR/010 (SAE1) | €479.20 Million | -17.86% | 1.53x | $1.07 Billion |
| JD HEALTH INTL LTD (8ZN) | $44.78 Billion | 0.85% | 0.37x | $15.56 Billion |
| IRWIN NATURALS INC. (97X) | $23.12 Million | 37.27% | 1.04x | $606.63K |
| Redcare Pharmacy NV (RDC) | $425.14 Million | -3.94% | 0.26x | $973.54 Million |
| Redcare Pharmacy NV (RDC) | $18.08 Million | -15.66% | 0.42x | $901.38 Million |
| ALIB.HL.INF.TEC.UNSP.ADR (TWYA) | $15.15 Billion | 3.54% | 0.37x | $8.42 Billion |
About SHOP APOTH. UNSP.ADR/010
Redcare Pharmacy NV operates the online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It offers prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare P… Read more